Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Three isolated compounds from Chinese prickly ash leaves showed antifungal bioactivity by damaging fungal biofilms and potentially recovering sensitivity to Fluconazole in vitro and in vivo [PMID:36211763]
Extracts from Zanthoxylum americanum (fruit and leaf) demonstrated broad-spectrum antifungal activity against 11 strains, including Candida albicans and Aspergillus fumigatus [PMID:15957372]
Hydroxy-γ-sanshool inhibited cell proliferation and induced G1 phase cell cycle arrest in vitro [PMID:35978957]
Polyphenols from Z. bungeanum showed therapeutic potential in animal models for ulcerative colitis, arthritis, asthma, COPD, cardiovascular disease, and neurodegenerative conditions [PMID:38343532]
Synthèse des preuves
Sources PubMed
- 1.PMID: 36462661 (2023) — The current situation of Zanthoxylum bungeanum industry and the research and application prospect. A review. · Fitoterapia
- 2.PMID: 34731789 (2022) — Composition, structure and flavor mechanism of numbing substances in Chinese prickly ash in the genus Zanthoxylum: A review. · Food chemistry
- 3.PMID: 36211763 (2022) — Antifungal compounds of Chinese prickly ash against drug-resistant Candida albicans. · Food chemistry: X
- 4.PMID: 38343532 (2024) — Research advances of Zanthoxylum bungeanum Maxim. polyphenols in inflammatory diseases. · Frontiers in immunology
- 5.PMID: 15957372 (2005) — Antifungal constituents of northern prickly ash, Zanthoxylum americanum mill.